Weight loss drugs are everywhere and recently Zepbound (tirzepitide) made big news when it became the first FDA-approved sleep apnea therapy for mild to moderate sleep apnea. In this episode, we will:
- Introduce and explain weight loss medications
- Review the studies that convinced the FDA to approve Zepbound for sleep apnea
- Provide an overview on this class of weight loss medications
- Evaluate the risks and determine who is a best match for this therapy
- Touch on the cost and difficulty in getting these drugs approved
- Revisit Apnimed's SynAIRgy press release and how it relates to our discussion in episode 110 of the podcast
Produced by: Maeve Winter
More
Thanks for listening and sleep well!
Sleep Unplugged with Dr. Chris Winter